Singapore markets closed

Orphazyme A/S (ORPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3000-0.0800 (-3.36%)
At close: 04:00PM EST
2.2800 -0.02 (-0.87%)
Pre-market: 08:04AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
13,152
0
-
0
Operating expenses
Research development
358,839
261,136
285,413
154,952
Selling general and administrative
477,791
342,199
49,842
75,334
Total operating expenses
841,829
608,534
335,954
231,652
Operating income or loss
-828,677
-608,534
-335,954
-231,652
Interest expense
13,068
14,114
4,803
3,453
Total other income/expenses net
-
-12,406
-2,477
-
Income before tax
-847,863
-635,161
-342,997
-235,100
Income tax expense
-2,252
-1,915
-5,500
-5,500
Income from continuing operations
-845,611
-633,246
-337,497
-229,600
Net income
-845,611
-633,246
-337,497
-229,600
Net income available to common shareholders
-845,611
-633,246
-337,497
-229,600
Basic EPS
-
-22.32
-16.87
-11.50
Diluted EPS
-
-22.32
-16.87
-11.50
Basic average shares
-
28,366
20,002
19,966
Diluted average shares
-
28,366
20,002
19,966
EBITDA
-
-615,847
-334,391
-230,281